Fingerprint
Dive into the research topics of 'Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer
M. Dror Michaelson, Donald S. Kaufman, Philip Kantoff, William K. Oh, Matthew R. Smith
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations